Medical Devices Startups

Amygdala Neurosciences is a biopharmaceutical company developing oral medications to treat alcohol and substance use disorders by targeting the ALDH2 enzyme. The company addresses unmet clinical needs in addiction treatment through novel pharmacotherapies.

1 investor

A drug discovery company focused on medicinal chemistry and preclinical research across multiple therapeutic areas.

1 investor

Everlife Analisa Resources is a laboratory and scientific solutions distributor founded in 1999, providing instruments, chemistries, consumables, software, and technical services to life sciences, analytical testing, and diagnostic markets across Asia. The company serves scientists, research institutions, biotechnology firms, and industries including pharmaceuticals, food, and chemicals.

1 investor

Anatomic Studios designs and produces custom prosthetic covers that emphasize personal expression and aesthetic choice alongside function. The company works with prosthetics clinics and users globally to create tailored cosmetic solutions for upper and lower limb prosthetics.

1 investor

Anatomiz3D develops patient-specific surgical planning solutions and tissue engineering products using 3D printing and bioprinting technologies for the healthcare industry. The company aims to improve surgical outcomes and eventually reduce organ transplant dependency through customized medical interventions.

1 investor

Anatoscope develops software that reconstructs and simulates a digital twin of a patient from data such as medical imaging or surface scans, working at the intersection of medical imaging and computer-aided design (CAD). Founded as a spin-off from Inria, CNRS, and the Grenoble-Alpes and Montpellier universities, it applies biomechanical simulation and digital design across medical fields via its subsidiaries.

1 investor

Andzonbio1 is a biotech start-up developing therapeutics and building a pipeline, supported by public and private funding sources in France. The company is backed by Inserm Transfert and AdBio partners, both focused on life sciences innovation and early-stage therapeutic investments.

1 investor

Anebulo Pharmaceuticals is developing selonabant, a drug candidate intended to reverse cannabis-induced toxicities, including acute CNS depression in children and acute cannabinoid intoxication in adults. The company is a clinical-stage pharmaceutical developer targeting conditions for which there are no approved treatments.

1 investor

AnewHealth provides comprehensive pharmacy services for people with chronic conditions and complex medical needs, helping optimize medication therapies and reduce healthcare costs. The company supports home- and community-based care through its ExactCare platform and advocates for policy changes to expand access to quality long-term care pharmacy services.

1 investor

Angel MedFlight provides air ambulance and medical transportation services for patients requiring long-distance transfers, equipped with intensive care capabilities and staffed with critical care medical professionals. The company serves patients needing trauma care, specialty treatment, rehabilitation, and international medical repatriation across state and country borders.

1 investor

AngioDynamics develops and manufactures medical devices aimed at treating serious diseases and improving patient outcomes. Founded in 1988, the company serves healthcare professionals and operates globally across North America, Europe, the Middle East, and South America.

1 investor

PCaVision is a diagnostic tool that combines multiparametric ultrasound imaging with AI algorithms to detect suspicious areas for prostate cancer, offering urologists a diagnostic pathway that does not require MRI. It is aimed at urologists, hospitals, and clinics, and is CE/MDR Class IIb certified for use in authorized EU markets.

1 investor

AngioInsight develops AI-driven diagnostic tools for earlier and more precise identification and management of coronary artery disease, serving clinicians and patients in cardiovascular healthcare.

1 investor

Animal Health Partners Toronto operates an emergency and specialty veterinary hospital providing specialized animal healthcare services. The facility combines advanced veterinary medicine practices with emergency care for companion animals.

1 investor

A German medical supply store (Sanitätshaus) offering health and orthopedic products along with individual advice and custom-fitted solutions for consumers. It focuses on aids intended to support daily life and health.

1 investor

Ankyra Therapeutics is a biopharmaceutical company developing drugs, with a team that has collectively contributed to bringing seven drugs to global market approval.

1 investor

Anne Arundel Dermatology Group provides general, surgical, and cosmetic dermatological services across the Mid-Atlantic and Southeastern regions. The practice delivers expert dermatological care with advanced treatment options for skin health.

1 investor

Anocis is a pharmaceutical drug discovery company focused on early-stage development in neuroscience, particularly ion channel research. The company serves pharmaceutical and biotech clients seeking collaborative drug discovery services and technologies.

1 investor

ANRis develops nucleic acid therapeutics using proprietary SNPD-siRNA technology for drug discovery and treatment delivery in medical and pharmaceutical applications.

1 investor

Ansana develops sterilization process management and control solutions for healthcare and pharmaceutical organizations, focusing on patient safety and operational efficiency.

1 investor

Ansella Therapeutics develops novel vaginal formulations for women's health conditions using biomimetic materials science and biomedical engineering, focused on treating menopause, vaginal dryness, dyspareunia, vaginal mucositis, endometriosis, uterine fibroids, and vaginal infections.

1 investor

AnserBio develops an oncology biotherapy that restores functional p53 tumor suppressor protein by delivering it through proprietary cell-derived nanovesicles (exosomes). It targets p53-mutant cancers with high unmet need, including colon, bladder, ovarian cancer, and glioblastoma.

1 investor

Antalgenics develops drugs and neurocosmetical products targeting dermatological and inflammatory conditions such as psoriatic pruritus, arthritic pain, and sensitive skin. The company focuses on pharmaceutical and cosmetic ingredient innovation for healthcare and personal care markets.

1 investor

Antaros Medical is a development partner to the pharmaceutical industry that uses medical imaging to provide evidence-based decision support during clinical drug development. It combines imaging technology with expertise in drug development and disease mechanisms.

1 investor